Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125576611 | 12557661 | 1 | I | 201104 | 20160711 | 20160714 | 20160714 | EXP | US-PFIZER INC-2016340292 | PFIZER | 66.00 | YR | F | Y | 0.00000 | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125576611 | 12557661 | 1 | PS | Genotropin MQ | SOMATROPIN | 1 | 0.2 MG, DAILY (EVERY DAY BEFORE BEDTIME INJECTION) | U | 20280 | .2 | MG | POWDER FOR SOLUTION FOR INJECTION | |||||||
| 125576611 | 12557661 | 2 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 250 MG (500MG 1/2 TABLET), 1X/DAY | 0 | 250 | MG | TABLET | QD | |||||||
| 125576611 | 12557661 | 3 | C | AVAPRO | IRBESARTAN | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
| 125576611 | 12557661 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 120 MG, DAILY | 0 | 120 | MG | |||||||||
| 125576611 | 12557661 | 5 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 12.5 MG, DAILY | 0 | 12.5 | MG | |||||||||
| 125576611 | 12557661 | 6 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 8 MEQ, 1X/DAY | 0 | 8 | MEQ | TABLET | QD | |||||||
| 125576611 | 12557661 | 7 | C | OMEGA 3 KRILL OIL | 2 | 500 MG, 2X/DAY | 0 | 500 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125576611 | 12557661 | 1 | Hypopituitarism |
| 125576611 | 12557661 | 2 | Diabetes mellitus |
| 125576611 | 12557661 | 3 | Blood pressure abnormal |
| 125576611 | 12557661 | 4 | Depression |
| 125576611 | 12557661 | 5 | Fluid retention |
| 125576611 | 12557661 | 6 | Blood potassium decreased |
| 125576611 | 12557661 | 7 | Blood cholesterol abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125576611 | 12557661 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125576611 | 12557661 | Thyroid cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125576611 | 12557661 | 1 | 2004 | 201605 | 0 | |
| 125576611 | 12557661 | 2 | 2000 | 0 | ||
| 125576611 | 12557661 | 4 | 2002 | 0 | ||
| 125576611 | 12557661 | 5 | 2006 | 0 | ||
| 125576611 | 12557661 | 7 | 2011 | 0 |